Rocco Trisolini

Prof. Rocco Trisolini

Interventional Pulmonology Unit, Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, 00168 Roma, Italy
orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018 in The Lancet Respiratory Medicine
Verified
Journal Article
Closed access
PSPaolo Spagnolo
Paolo Spagnolo
GRGiulio Rossi
Giulio Rossi
Rocco TrisoliniRocco Trisolini
Rocco Trisolini
NSNicola Sverzellati
Nicola Sverzellati
RBRobert P Baughman
Robert P Baughman
AWAthol U Wells
Athol U Wells

11 March 2016 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
LPLaurent Papazian
Laurent Papazian
ACAmanda Corley
Amanda Corley
DHDean Hess
Dean Hess
JFJohn F. Fraser
John F. Fraser
JFJean-Pierre Frat
Jean-Pierre Frat
EAElie Azoulay
Elie Azoulay

1 February 2006 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
MAMarco Alifano
Marco Alifano
Rocco TrisoliniRocco Trisolini
Rocco Trisolini
ACAlessandra Cancellieri
Alessandra Cancellieri
JRJean François Regnard
Jean François Regnard

5 November 2014 in Respiration
Verified
Journal Article
Open access
PDF file
EHErik H.F.M. van der Heijden
Erik H.F.M. van der Heijden
RCRoberto F. Casal
Roberto F. Casal
Rocco TrisoliniRocco Trisolini
Rocco Trisolini
DSDaniel Paul Steinfort
Daniel Paul Steinfort
BHBin Hwangbo
Bin Hwangbo
IGInterventional Pulmonology Task Force On Specimen Guidelines
Interventional Pulmonology Task Force On Specimen Guidelines
Rationale: Conventional transbronchial needle aspiration (TBNA) and endobronchial ultrasound (EBUS)-TBNA are widely accepted tools for the diagnosis and staging of lung cancer and the initial procedure of choice for staging. Obtaining adequate specimens is key to provide a specific histologic and molecular diagnosis of lung cancer. Objectives: To develop practice guidelines on the acquisition and preparation of conventional TBNA and EBUS-TBNA specimens for the diagnosis and molecular testing of (suspected) lung cancer. We hope to improve the global unification of procedure standards, maximize the yield and identify areas for research. Methods: Systematic electronic database searches were conducted to identify relevant studies for inclusion in the guideline [PubMed and the Cochrane Library (including the Cochrane Database of Systematic Reviews)]. Main Results: The number of needle aspirations with both conventional TBNA and EBUS-TBNA was found to impact the diagnostic yield, with at least 3 passes needed for optimal performance. Neither needle gauge nor the use of miniforceps, the use of suction or the type of sedation/anesthesia has been found to improve the diagnostic yield for lung cancer. The use of rapid on-site cytology examination does not increase the diagnostic yield. Molecular analysis (i.e. EGFR, KRAS and ALK) can be routinely performed on the majority of cytological samples obtained by EBUS-TBNA and conventional TBNA. There does not appear to be a superior method for specimen preparation (i.e. slide staining, cell blocks or core tissue). It is likely that optimal specimen preparation may vary between institutions depending on the expertise of pathology colleagues.

1 June 2007 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
Federico CappuzzoFederico Cappuzzo
Federico Cappuzzo
CLClaudia Ligorio
Claudia Ligorio
PJPasi A. Jänne
Pasi A. Jänne
LTLuca Toschi
Luca Toschi
ERElisa Rossi
Elisa Rossi
MVMarileila Varella-Garcia
Marileila Varella-Garcia
Purpose: In non–small-cell lung cancer (NSCLC), clinical and biologic predictors for epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor sensitivity have been identified in retrospective studies, and there is urgent need to validate these results in prospective trials. The ONCOBELL trial is a prospective phase II study evaluating gefitinib sensitivity in NSCLC patients who never smoked or have increased EGFR gene copy number or activation of the antiapoptotic protein Akt. Patients and Methods: EGFR gene copy number was evaluated using fluorescence in situ hybridization (FISH), and presence of phospho-Akt was evaluated using immunohistochemistry. Additional tests included immunohistochemistry analysis of EGFR, FISH analysis of HER2, and mutation analysis of EGFR, HER2, and K-ras. Results: From November 2004 to February 2006, 183 patients were screened, and 42 patients were enrolled onto the trial. We observed one complete and 19 partial responses, for an overall response rate (RR) of 47.6% (95% CI, 32.5% to 62.7%). Median duration of response was 6.1 months, median time to progression (TTP) was 6.4 months, 1-year survival rate was 64.3%, and median survival time was not reached. EGFR FISH–positive patients, compared with negative patients, had higher RR (68.0% v 9.1%, respectively; P < .001), longer TTP (7.6 v 2.7 months, respectively; P = .02), and a trend for longer survival (median survival not reached v 7.4 months, respectively; P = .3). Therapy was well tolerated, and there were no drug-related deaths. Median follow-up time was too short for significance tests of differences in survival outcomes. Conclusion: Gefitinib is active and well tolerated in patients with trial characteristics, and EGFR FISH analysis is an accurate predictor for such therapy.

1 November 2003 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
VAV. Ambrosini
V. Ambrosini
ACA. Cancellieri
A. Cancellieri
MCM. Chilosi
M. Chilosi
MZM. Zompatori
M. Zompatori
Rocco TrisoliniRocco Trisolini
Rocco Trisolini
Venerino PolettiVenerino Poletti
Venerino Poletti
This study describes five cases presenting an acute clinical course of pulmonary fibrosis, in the absence of specific precipitating factors.A retrospective chart review of five patients with histologically proved usual interstitial pneumonia was carried out in 2001–2002. Clinical data, bronchoalveolar lavage (BAL) findings, high resolution computed tomography and histological features were reported.On admission all cases presented hypoxemia and dyspnoea, while some showed an increase of carbohydrate antigen 19.9 or laboratory tests typical of infection, although appropriate cultures were all negative. Altogether, four subjects died and only one is on follow-up. A pattern of diffuse ground-glass or alveolar opacification superimposed on reticular and linear findings was evident on lung imaging in all cases. Marked neutrophilia, together with type II reactive cells hyperplasia, was detected on BAL.Histological findings, from open lung biopsy or autopsy, showed all the aspects of usual interstitial pnemonia with superimposed features of acute lung injury, such as diffuse alveolar damage, with or without hyaline membranes, type II reactive cells hyperplasia and numerous fibroblastic foci. This study also underlines the diagnostic value of bronchoalveolar lavageversusopen lung biopsy.